These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 29196028)
1. Serum Response Factor Promotes Dopaminergic Neuron Survival via Activation of Beclin 1-Dependent Autophagy. Cheng XY; Li SY; Mao CJ; Wang MX; Chen J; Wang F; Wang GH; Deng WB; Li XK; Liu CF Neuroscience; 2018 Feb; 371():288-295. PubMed ID: 29196028 [TBL] [Abstract][Full Text] [Related]
3. Up-regulation of autophagy-related gene 5 ( Hu ZY; Chen B; Zhang JP; Ma YY J Biol Chem; 2017 Nov; 292(44):18062-18074. PubMed ID: 28928221 [TBL] [Abstract][Full Text] [Related]
4. A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease. Jalewa J; Sharma MK; Gengler S; Hölscher C Neuropharmacology; 2017 May; 117():238-248. PubMed ID: 28223210 [TBL] [Abstract][Full Text] [Related]
5. Acrolein acts as a neurotoxin in the nigrostriatal dopaminergic system of rat: involvement of α-synuclein aggregation and programmed cell death. Wang YT; Lin HC; Zhao WZ; Huang HJ; Lo YL; Wang HT; Lin AM Sci Rep; 2017 Apr; 7():45741. PubMed ID: 28401906 [TBL] [Abstract][Full Text] [Related]
6. Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation. Ozbey G; Nemutlu-Samur D; Parlak H; Yildirim S; Aslan M; Tanriover G; Agar A Pharmacol Rep; 2020 Oct; 72(5):1397-1406. PubMed ID: 32207092 [TBL] [Abstract][Full Text] [Related]
7. VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease. Tang FL; Erion JR; Tian Y; Liu W; Yin DM; Ye J; Tang B; Mei L; Xiong WC J Neurosci; 2015 Jul; 35(29):10613-28. PubMed ID: 26203154 [TBL] [Abstract][Full Text] [Related]
8. Apelin-13 Protects Dopaminergic Neurons against Rotenone-Induced Neurotoxicity through the AMPK/mTOR/ULK-1 Mediated Autophagy Activation. Chen P; Wang Y; Chen L; Song N; Xie J Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171641 [TBL] [Abstract][Full Text] [Related]
9. Ablation of serum response factor in dopaminergic neurons exacerbates susceptibility towards MPTP-induced oxidative stress. Rieker C; Schober A; Bilbao A; Schütz G; Parkitna JR Eur J Neurosci; 2012 Mar; 35(5):735-41. PubMed ID: 22356487 [TBL] [Abstract][Full Text] [Related]
10. VGLUT2 Is a Determinant of Dopamine Neuron Resilience in a Rotenone Model of Dopamine Neurodegeneration. Buck SA; De Miranda BR; Logan RW; Fish KN; Greenamyre JT; Freyberg Z J Neurosci; 2021 Jun; 41(22):4937-4947. PubMed ID: 33893220 [TBL] [Abstract][Full Text] [Related]
11. Dopamine neuron loss by selective deletion of autophagy-related gene 5 is not exacerbated by MPTP toxicity in midbrain. Ren YH; Niu XY; Huang HJ; Hao XD; Wang PX; Chi YL; Ding YQ; Liao M Neurosci Lett; 2018 May; 675():140-144. PubMed ID: 29175031 [TBL] [Abstract][Full Text] [Related]
12. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease. Yang XY; Zhao EY; Zhuang WX; Sun FX; Han HL; Han HR; Lin ZJ; Pan ZF; Qu MH; Zeng XW; Ding Y Neurol Sci; 2015 Nov; 36(11):2027-33. PubMed ID: 26169757 [TBL] [Abstract][Full Text] [Related]
13. shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model. Zharikov AD; Cannon JR; Tapias V; Bai Q; Horowitz MP; Shah V; El Ayadi A; Hastings TG; Greenamyre JT; Burton EA J Clin Invest; 2015 Jul; 125(7):2721-35. PubMed ID: 26075822 [TBL] [Abstract][Full Text] [Related]
14. Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models. Liu J; Liu W; Lu Y; Tian H; Duan C; Lu L; Gao G; Wu X; Wang X; Yang H Autophagy; 2018; 14(5):845-861. PubMed ID: 29433359 [TBL] [Abstract][Full Text] [Related]
15. Autophagic modulation by rosuvastatin prevents rotenone-induced neurotoxicity in an in vitro model of Parkinson's disease. Kang SY; Lee SB; Kim HJ; Kim HT; Yang HO; Jang W Neurosci Lett; 2017 Mar; 642():20-26. PubMed ID: 28137648 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective efficacy of the glucocorticoid receptor modulator PT150 in the rotenone mouse model of Parkinson's disease. Latham AS; Rocha SM; McDermott CP; Reigan P; Slayden RA; Tjalkens RB Neurotoxicology; 2024 Jul; 103():320-334. PubMed ID: 38960072 [TBL] [Abstract][Full Text] [Related]
19. Flavin-containing monooxygenase, a new clue of pathological proteins in the rotenone model of parkinsonism. Li B; Yuan Y; Zhang W; He W; Hu J; Chen N Neurosci Lett; 2014 Apr; 566():11-6. PubMed ID: 24440618 [TBL] [Abstract][Full Text] [Related]
20. Dysregulation of bcl-2 enhanced rotenone-induced α-synuclein aggregation associated with autophagic pathways. Chen Y; Zhang N; Ji D; Hou Y; Chen C; Fu Y; Ge R; Zheng Q; Chen J; Wang H Neuroreport; 2018 Sep; 29(14):1201-1208. PubMed ID: 30059366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]